LISTER HOUSE PARTNERSHIP — All Prescriptions & Medications — Page 4
Practice Code: L85038 | TAUNTON, TA4 2BF
Showing results 151-200 of 571
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ready to serve 2.4 kcal/ml milkshake lower volume (0913011) | 165 | 538.3K | £6.6K | +33.2% ▲ |
| Insulin glargine | 163 | 950 | £6.5K | -42.6% ▼ |
| Levetiracetam | 162 | 12.9K | £1.9K | -64.6% ▼ |
| Carbamazepine | 162 | 12.3K | £416 | -45.4% ▼ |
| Estriol | 162 | 1,526 | £4.0K | -23.9% ▼ |
| Ferrous sulfate | 160 | 7,207 | £272 | -68.9% ▼ |
| Ispaghula husk | 159 | 8,010 | £1.3K | +20.7% ▲ |
| Prochlorperazine maleate | 159 | 5,851 | £473 | -21.3% ▼ |
| Oxybutynin | 157 | 10.4K | £594 | -17.6% ▼ |
| Clotrimazole | 154 | 5,480 | £353 | +58.9% ▲ |
| Tadalafil | 152 | 2,800 | £441 | -10.6% ▼ |
| Eplerenone | 149 | 3,990 | £546 | -43.8% ▼ |
| Sulfasalazine | 146 | 20.2K | £3.7K | +12.2% ▲ |
| Clarithromycin | 146 | 3,867 | £744 | -40.5% ▼ |
| Lactulose | 145 | 92.8K | £838 | -56.0% ▼ |
| Vitamin B compound | 139 | 10.0K | £306 | -0.2% vs avg |
| Docusate sodium | 137 | 10.9K | £808 | -63.0% ▼ |
| Irbesartan | 137 | 4,984 | £381 | -43.8% ▼ |
| Bumetanide | 134 | 9,274 | £910 | -50.8% ▼ |
| Betahistine hydrochloride | 131 | 11.1K | £424 | -45.1% ▼ |
| Cyclizine hydrochloride | 131 | 7,232 | £254 | -18.8% ▼ |
| Dorzolamide and timolol | 131 | 1,750 | £1.7K | -8.5% ▼ |
| Tiotropium bromide/olodaterol | 129 | 129 | £3.9K | +110.3% ▲ |
| Tamoxifen citrate | 128 | 4,178 | £357 | +55.4% ▲ |
| Diphtheria | 128 | 128 | £887 | +91.8% ▲ |
| Isophane insulin | 126 | 687 | £2.8K | +19.3% ▲ |
| Trazodone hydrochloride | 125 | 5,432 | £213 | -38.8% ▼ |
| Nicorandil | 123 | 8,820 | £1.4K | -14.6% ▼ |
| Insulin detemir | 123 | 715 | £5.7K | +57.1% ▲ |
| Zolpidem tartrate | 121 | 1,813 | £84 | +34.3% ▲ |
| Buprenorphine | 120 | 485 | £1.7K | -67.2% ▼ |
| Other multivitamin preparations | 120 | 5,028 | £1.7K | -30.6% ▼ |
| Calcipotriol | 119 | 11.3K | £5.2K | -30.1% ▼ |
| Pancreatin | 118 | 34.8K | £9.2K | +6.1% ▲ |
| Meloxicam | 118 | 3,822 | £117 | +78.4% ▲ |
| Lorazepam | 116 | 3,790 | £1.2K | -18.6% ▼ |
| Dexamethasone | 114 | 645 | £388 | -33.7% ▼ |
| Olanzapine | 113 | 3,683 | £363 | -69.5% ▼ |
| Insulin Lispro | 113 | 830 | £4.8K | +47.7% ▲ |
| Nefopam hydrochloride | 112 | 10.2K | £488 | -1.0% vs avg |
| 112 | 13.5K | £579 | -14.5% ▼ | |
| Hyoscine butylbromide | 109 | 8,129 | £616 | -53.2% ▼ |
| Sacubitril/valsartan | 108 | 5,236 | £8.2K | -54.9% ▼ |
| Umeclidinium bromide/vilanterol | 108 | 111 | £3.4K | -44.6% ▼ |
| 108 | 720 | £293 | -48.3% ▼ | |
| Mometasone furoate | 106 | 6,380 | £669 | -20.7% ▼ |
| Topiramate | 105 | 8,250 | £1.3K | -40.9% ▼ |
| Bempedoic acid/Ezetimibe | 102 | 2,767 | £5.1K | +67.0% ▲ |
| 102 | 49.5K | £319 | +11.9% ▲ | |
| Hypromellose | 101 | 1,520 | £565 | -23.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.